Enochian Biosciences
initial clinical study phase i open to all solid tumors focus on patients with pancreatic cancer phase i safety assessment ascending dose ranging cohort of up to patients dose level phase enrollment starting in late fixed dose cohort design one cohort cancer type assumes high response rate up to patients extending cohort into assuming responding tumor type seek breakthrough and or designation for accelerated development and approval data to support available end first half of | Enochian Biosciences
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
25 of 28
Related slides by other companies
Exscientia
Investor Presentation
August 2023
elucidate phase ongoing in advanced solid | Exscientia
Exscientia
Investor Presentation
November 2023
elucidate phase ongoing in advanced solid | Exscientia
Aeglea BioTherapeutics
Investor Presentation
October 2023
spy phase clinical trial design | Aeglea BioTherapeutics
Alkermes
Investor Day
March 2021
artistry phase efficacy expansion initiated following determination phase dose week lead in followed by combination of and either or cohorts a to a dose cohorts to dose phase efficacy expansion in solid tumors initiated at combination selected efficacy expansion in select solid tumors where previous responses were observed primary objectives safety and efficacy in combination with subcutaneous recommended phase dose administered once weekly administered once every three weeks secondary objectives include clinical profile and immunogenicity clinical pharmacodynamic effects all parts anti tumor activity phase and objective response rate and dor duration of response phase as fae | Alkermes
Other recent decks by Enochian Biosciences
See all presentations (3 decks)
Results
August 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io